Results from a pooled analysis of data from 12 studies have demonstrated a long-term survival benefit that extends through at least 10 years for patients with advanced melanoma treated with ipilimumab ...

These findings underscore the mechanistic elegance of interleukin (IL)-13 inhibition and highlight potential advantages of flexible dosing, according to the study's lead author, Eric L. Simpson, MD, ...

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic ...

An overview of the FIDELITY analysis, which pooled data from the FIGARO-DKD and FIDELIO-DKD trials in patients with type 2 diabetes and CKD. Rajiv Agarwal, MD, MS: FIDELITY is not a trial, it’s an ...

Please provide your email address to receive an email when new articles are posted on . Researchers measured health-related quality of life changes via the St. George’s Respiratory Questionnaire (SGRQ ...

Results presented at EuroPCR 2022 show notable reduction of blood pressure in patients on and off medications at six months PALO ALTO, Calif.--(BUSINESS WIRE)--ReCor Medical, Inc. (“ReCor”) and Otsuka ...

WHIPPANY, N.J.--(BUSINESS WIRE)--The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled analysis of three Phase III trials with finerenone 1, were ...

A new analysis of the STEP trails carried out by semaglutide manufacturer Novo Nordisk has analysed various trials to show ...

Please provide your email address to receive an email when new articles are posted on . A lower annualized rate of moderate/severe exacerbations and a prolonged time to first moderate/severe ...

A new analysis of the STEP trials carried out by semaglutide manufacturer Novo Nordisk has analyzed various trials to show ...